[Federal Register Volume 76, Number 67 (Thursday, April 7, 2011)]
[Notices]
[Page 19373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-8283]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]


The 14th Annual Food and Drug Administration-Orange County 
Regulatory Affairs Educational Conference in Irvine, California: New 
Regulatory Challenges

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of conference.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
conference: 14th Annual Educational Conference co-sponsored with the 
Orange County Regulatory Affairs Discussion Group (OCRA). The 
conference is intended to provide the drug, device, biologics, and 
dietary supplement industries with an opportunity to interact with FDA 
reviewers and compliance officers from the centers and District 
Offices, as well as from other industry experts. The main focus of this 
interactive conference will be product approval, compliance, and risk 
management in the three medical product areas. Industry speakers, 
interactive Q & A, and workshop sessions will also be included to 
assure open exchange and dialogue on the relevant regulatory issues.
    Date and Time: The conference will be held on June 8 and 9, 2011, 
from 7:30 a.m. to 5 p.m.
    Location: The conference will be held at the Irvine Marriott Hotel, 
18000 Von Karman Ave., Irvine, CA 92612.
    Contact: Linda Hartley, Office of Regulatory Affairs, Food and Drug 
Administration, 19701 Fairchild, Irvine, CA 92612, Voice: 949-608-4413, 
Fax: 949-608-4417; or Orange County Regulatory Affairs Discussion 
Group, Attention to Detail, 5319 University Dr., suite 641, Irvine, CA 
92612, Voice: 949-387-9046, Fax: 949-387-9047, Web site: http://www.ocra-dg.org. (FDA has verified the Web site address, but FDA is not 
responsible for any subsequent changes to the Web site after this 
document publishes in the Federal Register.)
    Registration and Meeting Information: See OCRA's Web site at http://www.ocra-dg.org. Contact Attention to Detail at 949-387-9046.
    Before May 1, 2011, registrations fees are as follows: $675.00 for 
members, $725.00 for non-members and $475.00 for FDA/Government/
Students.* After May 1, 2011, $725.00 for members, $775.00 for non-
members, and $475.00 for FDA/Government/Students.*
    * OCRA student rate applies to those individuals enrolled in a 
regulatory or quality-related academic program at an accredited 
institution. Proof of enrollment required.
    The registration fee will cover actual expenses including 
refreshments, lunch, materials, parking, and speaker expenses.
    If you need special accommodations due to a disability, please 
contact Linda Hartley (see Contact) at least 10 days in advance.
    Transcripts: Transcripts will not be available for the conference.

    Dated: April 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-8283 Filed 4-6-11; 8:45 am]
BILLING CODE 4160-01-P